Author(s): Annalisa Berzigotti 1 2 , Susana Seijo 1 2 , Enric Reverter 1 2 , Jaime Bosch [*] 3
Keywords
:
hepatic hemodynamics; hepatic venous pressure gradient; liver stiffness; noninvasive methods; ultrasound
Medscape: Continuing Medical Education Online
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Expert Reviews Ltd. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s) [trademark]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/expertgastrohep; (4) view/print certificate.
Release date: 28 January 2013; Expiration date: 28 January 2014
Learning objectives
Upon completion of this activity, participants will be able to:
* Analyze the initial evaluation of a patient with suspected portal hypertension
* Assess testing for gastroesophageal varices among patients with portal hypertension
* Evaluate patterns of portal hypertension on measurement of the hepatic venous pressure gradient
* Distinguish clinically significant elevations in the hepatic venous pressure gradient
Financial & competing interests disclosure
EDITOR
Elisa Manzotti
Publisher, Future Science Group, London, UK
Disclosure: Elisa Manzotti has disclosed no relevant financial relationships.
CME AUTHOR
Charles Vega
Health Sciences Clinical Professor, Residency Director, Department of Family Medicine, University of California, Irvine, CA, USA
Disclosure: Charles P Vega MD, has disclosed no relevant financial relationships.
AUTHORS AND CREDENTIALS
Annalisa Berzigotti, MD, PhD
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Disclosure: Annalisa Berzigotti, MD, PhD, has disclosed no relevant financial relationships.
Susana Seijo, MD
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Disclosure: Susana Seijo, MD, has disclosed no relevant financial relationships.
Enric Reverter, MD
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Disclosure: Enric Reverter, MD, has disclosed no relevant financial relationships.
Jaime Bosch, MD, PhD, Professor of Medicine; Chief, Hepatology Section
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Disclosure: Jaime Bosch, MD, PhD, has disclosed no relevant financial relationships.
Definition
Portal hypertension is a frequent syndrome - most often caused by chronic liver diseases - which is characterized by an increased portal pressure gradient...